These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9551172)

  • 1. [Lomefloxacin hydrochloride (Maxaquin), a long-acting fluoroquinolone (information for specialists)].
    Kuznetsovoĭ SM
    Antibiot Khimioter; 1998; 43(2):40-1. PubMed ID: 9551172
    [No Abstract]   [Full Text] [Related]  

  • 2. [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
    Padeĭskaia EN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(2):30-9. PubMed ID: 9551171
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
    Iakovlev SV
    Antibiot Khimioter; 1998; 43(10):42-5. PubMed ID: 9825110
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
    Iakovlev SV
    Urologiia; 2002; (1):11-4. PubMed ID: 11877963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Grepafloxacin (Raxar)].
    Friis HM
    Ugeskr Laeger; 1998 Jul; 160(30):4438-41. PubMed ID: 9691842
    [No Abstract]   [Full Text] [Related]  

  • 7. [Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives].
    Padeĭskaia EN
    Antibiot Khimioter; 1998; 43(10):4-9. PubMed ID: 9825101
    [No Abstract]   [Full Text] [Related]  

  • 8. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
    [No Abstract]   [Full Text] [Related]  

  • 9. ESGAB breakpoint determination: temafloxacin.
    Phillips I; Acar J; Baquero F; Bergan T; Forsgren A; Wiedemann B
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):991-2. PubMed ID: 1665417
    [No Abstract]   [Full Text] [Related]  

  • 10. Breakpoint determination: rufloxacin.
    Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):574-5. PubMed ID: 8404928
    [No Abstract]   [Full Text] [Related]  

  • 11. Lomefloxacin clinical pharmacokinetics.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    Clin Pharmacokinet; 1993 Jul; 25(1):6-19. PubMed ID: 8394795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bactericidal effects of maxaquin on mycobacterium tuberculosis].
    Kunichian AD; Mozhokina GN; Sokolova GB; Shapatava MN
    Probl Tuberk; 1997; (1):53-4. PubMed ID: 9162930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
    Symonds WT; Nix DE
    Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
    Jones RN
    J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial activity of a new difluorinated quinolone: lomefloxacin (SC-47111).
    Mattina R; Cocuzza G; Cocuzza CE
    J Chemother; 1989 Jul; 1(4 Suppl):159-61. PubMed ID: 16312351
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of lomefloxacin on the functional activity of the phagocytic system].
    Mozhokina GN; Gracheva MP; Sokolova GB
    Antibiot Khimioter; 1996 Mar; 41(3):25-8. PubMed ID: 8967798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of a fluoroquinolone-class disk for susceptibility tests.
    Barry AL; Fuchs PC
    Am J Med; 1993 Mar; 94(3A):17S-22S. PubMed ID: 8383918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
    Mikamo H; Kawazoe K; Izumi K; Ito K; Tamaya T
    Drugs; 1995; 49 Suppl 2():326-30. PubMed ID: 8549350
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, and Enterobacteriaceae.
    Rossolini GM; Valentini S; Vaiani G; Satta G
    J Chemother; 1989 Jul; 1(4 Suppl):173-6. PubMed ID: 16312356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.